NOS3 and B-cell non-Hodgkin lymphoma: The evaluation of NOS isoform expression levels in B-cell non-Hodgkin lymphoma tissues showed NOS1 more frequently expressed compared with NOS2 and NOS3 (94% of cases vs. 87% vs. 6%, respectively) [53].